HEPATIC FIBROSIS MARKER ABNORMAL

This adverse event was reported 14 times

These drugs are most commonly taken by patients reporting HEPATIC FIBROSIS MARKER ABNORMAL:

# Drug Count
0 AZATHIOPRINE 8
1 CYCLOSPORINE 8
2 EPINEPHRINE 8
3 FEXOFENADINE 8
4 LORATADINE 8
5 LORATADINE ORAL 8
6 MONTELUKAST 8
7 OMALIZUMAB 8
8 GLECAPREVIR AND PIBRENTASVIR 2
9 RESMETIROM 2
See all common drugs associated with HEPATIC FIBROSIS MARKER ABNORMAL

HEPATIC FIBROSIS MARKER ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RESMETIROM 2 0.0009
1 GLECAPREVIR AND PIBRENTASVIR 2 0.0002
2 EPINEPHRINE 8 0.0001
3 OMALIZUMAB 8 0.0001
4 AZATHIOPRINE 8 0.0001
5 LORATADINE 8 0.0001
6 CYCLOSPORINE 8 0.0001
7 BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE 1 0.0000
8 CANDESARTAN CILEXETIL 1 0.0000
9 ESTRADIOL TRANSDERMAL 1 0.0000
See all drugs enriched for association with HEPATIC FIBROSIS MARKER ABNORMAL